Voveran Emulgel 50gm Information
Voveran Emulgel 50gm is a commercial drug that is prescribed in the form of Ointment. Primarily, it is used for the treatment of Muscle Pain, Toothache, Rheumatic Pain. The alternative uses of Voveran Emulgel 50gm have also been explained below.
The optimal dosage of Voveran Emulgel 50gm is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Voveran Emulgel 50gm can also lead to other problems, which have been listed below. These side effects of Voveran Emulgel 50gm are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Voveran Emulgel 50gm's effect is Severe during pregnancy and Mild for lactating mothers. Warnings related to Voveran Emulgel 50gm's effects on the liver, heart and kidney, if any, have been listed below.
Voveran Emulgel 50gm is contraindicated in people with pre-existing medical conditions like Stomach Infection, Skin Rash, Stroke as it can result in adverse effects. Other conditions have been mentioned below in the Voveran Emulgel 50gm contraindications section.
Additionally, Voveran Emulgel 50gm may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Voveran Emulgel 50gm, it is important to know that it is safe while driving, and is habit-forming.
Voveran Emulgel 50gm Benefits & Uses
Voveran Emulgel 50gm is used to treat the following -
Main Benefits
- Muscle Pain (Read More - Home Remedies for Muscle Aches)
- Toothache (Read More - Home remedies for toothache)
- Rheumatic Pain
Other Benefits
- Headache
- Joint Pain (Read More - How to Relieve Joint Pain Naturally: Best Home Remedies)
- Osteoarthritis
- Rheumatoid Arthritis
- Ankylosing spondylitis
- Gout (Read More - Home remedies for gout pain)
- Migraine (Read More - Home remedies for migraines)
- Leg Pain (Read More - Home remedies for leg pain and weakness)
- Body Pain (Read More - Home Remedies for Body Pain)
- Sciatica (Read More - Home Remedies for Sciatica: Alleviate Pain Naturally)
- Foot Pain (Read More - How to Ease Foot Pain at Home with Natural Techniques)
Voveran Emulgel 50gm Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Voveran Emulgel 50gm Side Effects
Based on research, the following side effects have been observed when Voveran Emulgel 50gm is used -
Severe
- Nephrotoxic
- Constipation (Read More - Home remedies for constipation)
- Diarrhoea
- Pancreatic inflammation
- Liver Damage
Moderate
- Fluid Retention
- पेट दर्द
- Arrhythimia
Mild
- Skin Rash (Read More - DIY Skin Rash Relief: Simple Home Remedies That Work)
- Nausea or vomiting
Voveran Emulgel 50gm Related Warnings
-
Is the use of Voveran Emulgel 50gm safe for pregnant women?
Pregnant women may get severe side effects after taking Voveran. If you are pregnant, do not take Voveran without a doctor's advice.
Severe -
Is the use of Voveran Emulgel 50gm safe during breastfeeding?
Voveran may have very limited harmful effects for breastfeeding women.
Mild -
What is the effect of Voveran Emulgel 50gm on the Kidneys?
There may be some severe side effects of Voveran on your kidney. Do not take it unless a doctor says so.
Severe -
What is the effect of Voveran Emulgel 50gm on the Liver?
Voveran can cause side effects that could harm the liver. So medical advice before taking it is necessary.
Severe -
What is the effect of Voveran Emulgel 50gm on the Heart?
Voveran may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Moderate
Severe Interaction of Voveran Emulgel 50gm with Other Drugs
Voveran Emulgel 50gm should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Voveran Emulgel 50gm Contraindications
If you are suffering from any of the following diseases, you should not take Voveran Emulgel 50gm unless your doctor advises you to do so -
- Edema
- Stomach Infection
- Gastrointestinal Bleeding
- Kidney Disease
- Skin Rash
- Heart Attack
- Stroke
- Asthma
- Anemia
- Heart Failure
- Liver Disease
- Peptic Ulcer
Frequently asked Questions about Voveran Emulgel 50gm
-
Is this Voveran Emulgel 50gm habit forming or addictive?
Forming a habit of Voveran Emulgel 50gm has not been reported.
No -
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Voveran Emulgel 50gm since it will not make you feel sleepy.
Safe -
Is it safe?
Yes, but take Voveran Emulgel 50gm only as per medical advice.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
No, Voveran Emulgel 50gm is not used to treat mental disorders.
No
Voveran Emulgel 50gm Interactions with Food and Alcohol
-
Interaction between Food and Voveran Emulgel 50gm
There isn't any research available on the side effects of taking Voveran Emulgel 50gm with food.
Unknown -
Interaction between Alcohol and Voveran Emulgel 50gm
Taking Voveran Emulgel 50gm with alcohol can have severely harmful effects on your health.
Severe
See all substitutes for Voveran
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
